A detailed history of Dimensional Fund Advisors LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 803,458 shares of MRVI stock, worth $5.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
803,458
Previous 920,661 12.73%
Holding current value
$5.91 Million
Previous $6.03 Million 15.51%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$5.11 - $8.76 $598,907 - $1.03 Million
-117,203 Reduced 12.73%
803,458 $6.97 Million
Q4 2023

Feb 07, 2024

SELL
$4.7 - $9.87 $1.02 Million - $2.15 Million
-217,881 Reduced 19.14%
920,661 $6.03 Million
Q3 2023

Nov 09, 2023

BUY
$9.14 - $12.85 $1.93 Million - $2.72 Million
211,370 Added 22.8%
1,138,542 $11.4 Million
Q2 2023

Aug 09, 2023

BUY
$12.09 - $15.0 $6.66 Million - $8.26 Million
550,964 Added 146.45%
927,172 $11.5 Million
Q1 2023

May 12, 2023

BUY
$12.99 - $16.48 $81,382 - $103,247
6,265 Added 1.69%
376,208 $5.27 Million
Q4 2022

Feb 09, 2023

BUY
$12.5 - $24.78 $397,400 - $787,805
31,792 Added 9.4%
369,943 $5.29 Million
Q3 2022

Nov 10, 2022

SELL
$20.6 - $30.37 $182,413 - $268,926
-8,855 Reduced 2.55%
338,151 $8.63 Million
Q2 2022

Aug 12, 2022

BUY
$26.05 - $37.48 $5.99 Million - $8.61 Million
229,847 Added 196.18%
347,006 $9.86 Million
Q1 2022

May 13, 2022

BUY
$24.46 - $40.92 $2.41 Million - $4.04 Million
98,698 Added 534.63%
117,159 $4.13 Million
Q4 2021

Feb 09, 2022

BUY
$35.0 - $45.94 $26,985 - $35,419
771 Added 4.36%
18,461 $774,000
Q3 2021

Nov 12, 2021

BUY
$36.8 - $60.62 $650,992 - $1.07 Million
17,690 New
17,690 $868,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $967M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.